|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn947837531 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
151106t20162016nyua oa 001 0 eng |
| 010 |
|
|
|a 2019719454
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d N$T
|d YDXCP
|d OCLCF
|d SNK
|d DKU
|d AUW
|d MHW
|d BTN
|d IGB
|d D6H
|d VTS
|d AGLDB
|d G3B
|d S8J
|d S9I
|d STF
|d OCLCO
|d VLY
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|z 9781634842747
|
| 020 |
|
|
|z 163484274X
|
| 020 |
|
|
|a 9781634842754
|q (ebook)
|
| 020 |
|
|
|a 1634842758
|
| 029 |
1 |
|
|a AU@
|b 000062420138
|
| 035 |
|
|
|a (OCoLC)947837531
|
| 050 |
0 |
0 |
|a RL793
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.5
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Epidermolysis bullosa (EB) :
|b prevalence, clinical manifestations and management /
|c Hubert Mullins, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Science Publishers, Incorporated ,
|c [2016]
|
| 264 |
|
4 |
|c ©2016
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Dermatology--laboratory and clinical research
|
| 500 |
|
|
|a "Nova Biomedical."
|
| 504 |
|
|
|a Includes bibliographical research and index.
|
| 588 |
|
|
|a Description based on print version record.
|
| 505 |
0 |
|
|a EPIDERMOLYSIS BULLOSA (EB) PREVALENCE, CLINICAL MANIFESTATIONS AND MANAGEMENT ; EPIDERMOLYSIS BULLOSA (EB) PREVALENCE, CLINICAL MANIFESTATIONS AND MANAGEMENT ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 EPIDERMOLYSIS BULLOSA ACQUISITA ; ABSTRACT; INTRODUCTION; HISTORY ; EPIDEMIOLOGY ; ETIOLOGY ; PATHOGENESIS ; CLINICAL PRESENTATION ; Clinical Phenotypes ; EBA and Associations with Other Diseases ; DIAGNOSIS; TREATMENT ; Current Treatment Options for EBA ; Future Treatment Modalities ; PROGNOSIS AND PROFILAXIS ; REFERENCES
|
| 505 |
8 |
|
|a Chapter 2 IMMUNOFLUORESCENCE MAPPING FOR DIAGNOSIS OF INHERITED EPIDERMOLYSIS BULLOSA ABSTRACT; INTRODUCTION; Immunofluorescence Mapping ; Biopsy Technique; Antibodies ; Staining Procedure ; Interpretation of Results ; Epidermolysis Bullosa Simplex (EBS) ; Junctional Epidermolysis Bullosa (JEB) ; Dystrophic Epidermolysis Bullosa (DEB) ; Kindler Syndrome ; Prenatal Diagnosis ; CONCLUSION ; REFERENCES; Chapter 3 NUTRITION FOR CHILDREN AND ADOLESCENTS WITH EPIDERMOLYSIS BULLOSA ; ABSTRACT; INTRODUCTION ; NUTRITIONAL REQUIREMENTS ; Energy and Proteins ; Micronutrients
|
| 505 |
8 |
|
|a Dietary Fiber and Water Requirements NUTRITIONAL THERAPY ; GROWTH ASSESSMENT ; Growth Curves ; Growth and Nutritional Profile and Risk of EB Patients ; CLINICAL CASE REPORT ; General Data ; Food Intake Data for the First Year of Life ; Clinical Manifestations that Affect Food Intake, Dietary Characteristics, and Bowel Movements ; Birth Data; Anthropometric Data ; WEIGHT-FOR-AGE, HEIGHT-FOR-AGE, AND BMI-FOR-AGE GROWTH CURVES ; ESTIMATED ENERGY REQUIREMENT ; Method 01 (Specific Equation for EB Patients) ; Method 02 (100 to 150% of the Estimated Energy Requirement)
|
| 505 |
8 |
|
|a HABITUAL FOOD INTAKE* AND INTAKE ADEQUACY GLOBAL NUTRITIONAL DIAGNOSIS ; CONCLUSION ; REFERENCES ; Chapter 4 WOUND HEALING AND SKIN CARE IN INHERITED EPIDERMOLYSIS BULLOSA ; ABSTRACT ; INTRODUCTION ; SKIN CARE OF THE EB NEWBORN AND INFANT ; EB CARE FROM CHILDHOOD TO ADULT ; WOUND CARE ; Dry to Lightly Exuding Wounds ; Heavy Exuding Wounds ; Critically Colonized and Infected Wounds ; HYPERKERATOTIC AND CRUSTED LESIONS ; EXUBERANT GRANULATION TISSUE ; Itch Management; PAIN MANAGEMENT ; Pain Related to Nursing Procedures ; EARLY DIAGNOSIS OF SQUAMOUS CELL CARCINOMA (SCC)
|
| 505 |
8 |
|
|a THERAPEUTIC PATIENT EDUCATION CONCLUSION ; REFERENCES ; Chapter 5 STRATEGIES INTEGRATING GENE THERAPY AND TISSUE ENGINEERING INTO THE DEVELOPMENT OF TREATMENTS FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA ; ABSTRACT; INTRODUCTION ; THERAPIES IN DEVELOPMENT ; Protein Replacement Therapy ; Cell Therapy; Gene Therapy; Vectors Used in Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa ; Gene Edition: Edition or Correction of Mutated Genomic Sequences ; COMBINING GENE THERAPY AND TISSUE ENGINEERING TO TREAT RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Diseases of the Skin
|x Mucous Membranes.
|
| 650 |
|
0 |
|a Epidermolysis bullosa.
|
| 650 |
|
2 |
|a Epidermolysis Bullosa
|
| 650 |
|
6 |
|a Épidermolyse bulleuse simple.
|
| 650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Clinical Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Diseases
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Internal Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a Epidermolysis bullosa
|2 fast
|
| 700 |
1 |
|
|a Mullins, Hubert,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Epidermolysis bullosa (EB)
|d New York : Nova Science Publishers, Inc. , [2016]
|z 9781634842747
|w (DLC) 2015956839
|
| 830 |
|
0 |
|a Dermatology--laboratory and clinical research series.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1226097
|z Texto completo
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 12759156
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1226097
|
| 994 |
|
|
|a 92
|b IZTAP
|
